TABLE 1

Patient Demography and Analysis

MBq injectedMaximal SUV/PUV/BGVMean SUV/PUV/BGVTumor volume (mm3)
Patient no.Patient age (y)18F-FDG64Cu-TP3805BC typeER/PR/HER218F-FDG64Cu-TP380518F-FDG64Cu-TP380518F-FDG64Cu-TP3805
PET/CT
 142370110.6IDC+/+/−12.86.86.53.486,0845,323
LN-1.11.0LN-1.4.9LN-1.5.5LN-1.2.4LN-1.28LN-1.28
 246370107.3IDC+/+/−5.57.03.13.85,0284,714
LN-1.1.8LN-1.2.6LN-1.3.1LN-1.3.4LN-1.59LN-1.49
LN-2.2.3LN-2.2.4LN-2.0.89LN-2.1.2LN-2.38LN-2.31
 349370125.8IDC+/+/−2.22.11.20.9113113
 452370125.8IDC−/−/+5.24.72.82.32,6141,726
LN-1.5.2LN-1.4LN-1.1.3LN-1.2.1LN-1.509LN-1.402
 544370144.3IDC+/+/+1.751.90.90.91,3851,018
 659370140.6IDC+/+/−5.04.42.62.72,6172,651
PEM
 168370144.6IDC+/+/?6.76.25.25.6509402
 257370140.6IDC+/−/+9.67.98.56.93,8184,714
 380370144.6IDC+/+/−1.93.02.32.414198
 446370142.5ILoC+/+/−4.33.74.93.4509346
 539370159.1IDC+/−/?5.14.75.74.97851,357
 659370162.8IDC+/+/?11.611.813.611.97,8126,912
 739370144.3IDC+/+/−2.92.23.41.83,1782,828
 855370151.7ILoC+/+/−3.03.32.62.7445549
3.13.52.52.7395497
 952370159.1IPaC+/−/+7.35.86.76.31,8471,357
 1058370140.6IDC+/+/−6.25.45.74.81,4361,767
 1155370144.3IDC+/−/?2.63.12.93.3268381
 1268370155.4IDC+/+/−2.73.12.92.91,1501,767
 1326370151.7HGMC+/−/−4.52.73.82.96961,150
  • IDC = invasive ductal carcinoma; LN = lymph node; ILoC = invasive lobular carcinoma; IPaC = invasive papillary carcinoma; HGMC = high-grade mammary carcinoma.